Korro Bio, Inc.

48.65 USD
+1.70 (+3.62%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Korro Bio, Inc. stock is down -0.9% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 February’s closed higher than January. 100% of analysts rate it a buy.

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.